CF Industries Reports Strong Q1 2026, But Litigation Gain Masks Underlying Normalization

What happened

CF Industries posted Q1 2026 net earnings of $615 million and adjusted EBITDA of $983 million, benefiting from a $170 million litigation settlement. Excluding this one-time gain, adjusted EBITDA would have been approximately $813 million, still robust but reflecting the ongoing normalization of nitrogen prices from 2024 peaks. The company continues to generate strong free cash flow, supported by high plant utilization and a favorable North American gas cost advantage. However, the earnings beat is partly artificial, and underlying trends show a gradual softening in realized nitrogen prices amid global supply additions. Investors should view the headline numbers with caution, as the core business is performing at mid-cycle levels rather than exhibiting new upward momentum.

Implication

The Q1 results confirm CF's strong operational position and ability to generate cash even as nitrogen prices normalize. However, the litigation gain creates a distorted comparison. For long-term investors, the attractive entry remains near $70, where the stock prices in a more conservative nitrogen scenario. The underlying cash flow supports the base case valuation of $85, but any upside beyond that hinges on sustained nitrogen tightness or successful low-carbon ammonia monetization. Maintain a patient approach.

Thesis delta

The first-quarter results appear strong but are skewed by a $170 million litigation gain. Core adjusted EBITDA of ~$813 million aligns with a mid-cycle environment, not a breakout. This reinforces the WAIT rating, as the stock likely already prices in the positive cash flow, and the risk of nitrogen price softening later in 2026 persists.